ENTERA BIO LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.99 USD | -11.16% |
|
-33.22% | +231.67% |
Chart calendar Entera Bio Ltd.
c3835dd4274f2d.TZaQr5XULrck_7Vgoqmu-uPp8keoobOKHFyvsy8DVnc.F8zm9calH4FKmNwzl5DkgteKuBH_k4DSTAbq6nZrJRUa-NeW3uZI83OKhQ~9756738ebf4fe89aa645390b72554257
Upcoming events on Entera Bio Ltd.
Past events on Entera Bio Ltd.
| 2024-03-08 04:05 pm | Q4 2023 Earnings Release |
| 2024-02-14 08:00 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-14 07:30 am | Q3 2023 Earnings Release |
| 2023-10-18 02:00 pm | BIO Investor Forum |
| 2023-10-15 04:30 pm | ASBMR Meeting - Poster No LB SUN-646 |
| 2023-10-14 04:30 pm | ASBMR Meeting - Poster No SAT-456 |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-11 04:05 pm | Q2 2023 Earnings Release |
| 2023-05-05 08:05 pm | Q1 2023 Earnings Release |
| 2023-03-31 04:00 pm | Q4 2022 Earnings Release |
| 2023-02-16 08:00 am | SVB Securities Global Biopharma Conference |
| 2022-11-10 04:15 pm | Q3 2022 Earnings Release |
| 2022-09-14 03:30 pm | H.C. Wainwright Global Investment Conference |
| 2022-09-11 02:00 pm | American Society for Bone and Mineral Research Meeting |
| 2022-08-11 06:30 am | Interim 2022 Earnings Release |
| 2022-05-18 08:00 am | Q1 2022 Earnings Call |
| 2022-05-12 06:30 am | Q1 2022 Earnings Release |
| 2022-03-30 10:30 am | Maxim Group Virtual Growth Conference |
| 2022-03-08 08:30 am | FY 2021 Earnings Call |
| 2022-03-08 06:30 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,37 0,14 153.47% | 0,57 0,54 5.16% | 0,13 0,18 -24.72% | 0,00 0,03 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,5 -11,0 -4.5% | -11,1 -11,4 2.24% | -12,2 -13,4 9.05% | -13,0 -14,7 11.27% | -8,89 -9,63 7.65% | -9,70 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,8 -10,4 -4.23% | -9,96 -10,3 3.1% | -12,2 -37,9 67.71% | -12,9 -14,6 11.25% | -8,86 -9,57 7.37% | -9,70 |
|
Net income Million USD | Released Forecast Spread | -10,8 -10,4 -4.23% | -9,98 -10,3 2.91% | -12,2 -26,4 53.88% | -13,1 -14,7 10.87% | -8,89 -9,59 7.35% | -9,70 |
|
EPS USD | Released Forecast Spread | -0,89 -0,81 -9.88% | -0,54 -0,56 3.57% | -0,47 -1,05 55.38% | -0,45 -0,49 8.16% | -0,31 -0,32 3.13% | -0,25 |
| Announcement Date | 26/03/20 | 18/03/21 | 08/03/22 | 31/03/23 | 08/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,17 0,08 94.87% | 0,07 0,09 -23.81% | 0,04 0,05 -12% | 0,01 0,00 - | 0,01 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,12 -4,15 0.76% | -3,84 -5,16 25.64% | -3,25 -5,26 38.25% | -2,87 -4,31 33.59% | -3,07 -3,89 21.12% | -2,21 -3,46 36.07% | -2,33 -2,00 -16.5% | -2,39 -2,50 4.56% | -1,93 -2,70 28.44% | -2,10 | -2,30 | -2,50 | -2,80 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4,73 -11,5 141.22% | -3,79 -5,94 36.14% | -3,19 -5,39 40.88% | -2,87 -4,31 33.4% | -3,08 -3,89 20.79% | -2,19 -3,46 36.71% | -2,33 -2,00 -16.25% | -2,35 -2,50 6% | -2,00 -2,70 26.11% | -2,10 | -2,30 | -2,50 | -2,80 | |
|
Net income Million USD | Released Forecast Spread | 4,92 -6,22 179.07% | -3,78 -5,20 27.27% | -3,19 -4,92 35.3% | -3,07 -4,31 28.91% | -3,04 -3,89 21.97% | -2,19 -3,46 36.71% | -2,33 -2,00 -16.25% | -2,38 -2,50 4.84% | -2,00 -2,70 26.11% | -2,10 | -2,30 | -2,50 | -2,80 | |
|
EPS USD | Released Forecast Spread | 0,21 -0,23 190% | -0,13 -0,18 26.76% | -0,11 -0,16 31.25% | -0,11 -0,14 18.52% | -0,10 -0,12 13.04% | -0,08 -0,12 33.33% | -0,08 -0,07 -14.29% | -0,08 -0,09 11.11% | -0,07 -0,08 12.5% | -0,06 | -0,06 | -0,06 | -0,06 | -0,08 |
| Announcement Date | 08/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 31/03/23 | 05/05/23 | 11/08/23 | 14/11/23 | 08/03/24 | - | - | - | - | - |
More events
Past sector events for Entera Bio Ltd.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENTX Stock
- Calendar Entera Bio Ltd.
